Research Article

MIP-T3 Expression Associated with Defects of Ciliogenesis in Airway of COPD Patients

Table 1

Subject characteristics.

Nonsmoker groupHealthy smoker groupCOPD smoker

Total of subjects (n)211718
Sex (male, n (%))18 (85.71)16 (94.11)17 (94.44)
Age (year, mean ± SD)58.57 ± 11.2357.35 ± 10.4062.22 ± 9.40
Smoking index (pack years, mean ± SD)28.91 ± 18.4946.37 ± 17.66
Disease constitution carcinoma, n (%)19 (90.47)16 (94.11)17 (94.44)
FEV1(L, mean ± SD)2.30 ± 0.782.69 ± 0.631.79 ± 0.47
FVC (L, mean ± SD)2.97 ± 0.983.58 ± 0.873.04 ± 0.51
FVC%pred (mean ± SD)84.24 ± 6.6286.74 ± 7.0181.52 ± 5.22
FEV1/FVC (mean ± SD)78.29 ± 6.7875.53 ± 8.1058.33 ± 10.23
FEV1%pred (mean ± SD)96.76 ± 10.1094.12 ± 12.9265.89 ± 15.44

FEV1: forced expiratory volume in the first second; FVC: forced vital capacity. vs nonsmoker group, value <0.05. vs healthy smoker group, value <0.05.